Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

AI for Heart Failure Care Is Evolving Rapidly, THT 2026 Makes Clear

News Conference News THT 2026

AI for Heart Failure Care Is Evolving Rapidly, THT 2026 Makes Clear

March 10, 2026

Presentation THT 2026

Evaluating Electronic Health Record-Integrated Artificial Intelligence System In Combining Structured and Unstructured Data to Make Clinical Trial Eligibility Determination

Presenter: Trejeeve Martyn

March 03, 2026

Presentation THT 2026

EHR-Integrated Predictive Artificial Intelligence Decision Support System Reduces Heart Failure Readmissions, Improves Survival, and Eliminates Racial Disparities in a Safety-Net Health System

Presenter: Lucas Zier

March 03, 2026

AI-Enabled Virtual HF Care May Help Boost GDMT, Stabilize Weight

News Conference News THT 2026

AI-Enabled Virtual HF Care May Help Boost GDMT, Stabilize Weight

March 03, 2026

Presentation THT 2026

Artificial Intelligence Meets Real-World Heart Failure: Early Results from the HF-TRACK Trial

Presenter: Shamus Husheer

March 03, 2026

Presentation THT 2026

Post-Discharge Trajectories of Artificial Intelligence-Enabled Electrocardiogram in Patients with Heart Failure

Presenter: Hak Seung Lee

March 03, 2026

Presentation THT 2026

Artificial Intelligence: Framing the Future of HF Diagnostics and Clinical Decision Making

Presenter: Anuradha (Anu) Lala-Trindade (Lala)

March 02, 2026

THT 2026: What to Expect in Boston

News Conference News THT 2026

THT 2026: What to Expect in Boston

February 23, 2026

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

News Conference News THT 2025

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

February 13, 2025

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Presentation THT 2025

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Presenter: JoAnn Lindenfeld

February 13, 2025

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

Presentation THT 2025

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: David Cohen

February 13, 2025

This Strategy Has Saved the Startup Medical Device Sector

Presentation THT 2025

This Strategy Has Saved the Startup Medical Device Sector

Presenter: William Abraham

February 13, 2025

Down-Stream Challenges: Reimbursement and Guidelines

Presentation THT 2025

Down-Stream Challenges: Reimbursement and Guidelines

Presenter: Philip Adamson

February 13, 2025

Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 1

Presentation THT 2025

Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 1

Presenter: Harry Rowland

February 13, 2025

Regulatory Considerations for the Use of AI for Treating Patients With Heart Failure: The Intersection of Drugs and Devices

Presentation THT 2025

Regulatory Considerations for the Use of AI for Treating Patients With Heart Failure: The Intersection of Drugs and Devices

Presenter: Alex Cadotte

February 13, 2025

Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 2

Presentation THT 2025

Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 2

Presenter: Kartik Sundareswaran

February 13, 2025

Automated Read of Echocardiogram to Identify Cardiomyopathy and Valvular Heart Disease

Presentation THT 2024

Automated Read of Echocardiogram to Identify Cardiomyopathy and Valvular Heart Disease

Presenter: Akhil Narang

March 05, 2024

Heart Failure Diagnosis Using Wearable Devices

Presentation THT 2024

Heart Failure Diagnosis Using Wearable Devices

Presenter: Rohan Khera

March 05, 2024

Utilization of 12-Lead ECG in Diagnostics and Management of Cardiomyopathy

Presentation THT 2024

Utilization of 12-Lead ECG in Diagnostics and Management of Cardiomyopathy

Presenter: Christopher Haggerty

March 05, 2024

Regulatory Aspects of Implementing AI into Heart Failure Diagnostics and Therapeutics

Presentation THT 2024

Regulatory Aspects of Implementing AI into Heart Failure Diagnostics and Therapeutics

Presenter: Haider Warraich

March 05, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.